Reports: Novartis no longer pursuing Gen-Probe

Novartis is reportedly no longer looking into buying diagnostic test maker Gen-Probe, the Wall Street Journal says, citing sources. Life Technologies and Thermo Fisher Scientific had also expressed interest in the company, but dropped their pursuits last month. News

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.